Literature DB >> 33371824

Tanzanian women´s knowledge about Cervical Cancer and HPV and their prevalence of positive VIA cervical screening results. Data from a Prevention and Awareness Campaign in Northern Tanzania, 2017 - 2019.

Antje Henke1, Ulrike Kluge2, Theda Borde3, Bariki Mchome4, Furaha Serventi1, Oliver Henke1.   

Abstract

Background: 14.9 million women (≥15 years) in Tanzania are at risk of developing cervical cancer. Limited cancer care facilities, prevention programs and sparse knowledge among community members and healthcare workers contribute to late-stage presentation leading to a high mortality rate. Objective: This study aims to scientifically accompany prevention and awareness campaigns (PrevACamp) in northern Tanzania in its real-world settings to obtain (1) a better understanding about cervical cancer and HPV knowledge amongst female PrevACamp participants and (2) to determine the prevalence of pre-cancerous lesions among women undergoing cervical cancer VIA screening. Method: Cross-sectional survey among PrevACamp attendees in two regions in Northern Tanzania. Two data collections tools were used: Questionnaires and clinical data from VIA screening. Data were collected from October 2017 to March 2019.
Results: 2,192 PrevACamp attendees were interviewed and 2,224 received VIA screening. There was significant nescience on cervical cancer regardless of education level, resident status, or number of children as well as nescience on HPV in all age groups, especially in urban areas and misconceptions about cancer. Screening revealed VIA positivity rate of 3.1%.
Conclusion: There is an alarming lack of knowledge about cervical cancer and, to a lesser Extent, about HPV among the study participants. Having health insurance influenced the level of knowledge significantly. Outreach programs in rural areas appear to target the population in need of health education. Low positive VIA screening results are paralleled with lower HIV rates among the women. We assume that the high density of primary health care coverage in northern Tanzania contributes to these findings..

Entities:  

Keywords:  Cervical Cancer; HPV; Tanzania; cancer prevention; via screening

Mesh:

Year:  2021        PMID: 33371824      PMCID: PMC7782163          DOI: 10.1080/16549716.2020.1852780

Source DB:  PubMed          Journal:  Glob Health Action        ISSN: 1654-9880            Impact factor:   2.640


  26 in total

1.  Commentary: infection-related cancers in low- and middle-income countries: challenges and opportunities.

Authors:  Edgar P Simard; Ahmedin Jemal
Journal:  Int J Epidemiol       Date:  2013-02       Impact factor: 7.196

2.  Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators.

Authors:  Susan Chirwa; Mulindi Mwanahamuntu; Sharon Kapambwe; Gracilia Mkumba; Jeff Stringer; Vikrant Sahasrabuddhe; Krista Pfaendler; Groesbeck Parham
Journal:  Glob Health Promot       Date:  2010-06

3.  Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania.

Authors:  Powell Perng; Wei Perng; Twalib Ngoma; Crispin Kahesa; Julius Mwaiselage; Sofia D Merajver; Amr S Soliman
Journal:  Int J Gynaecol Obstet       Date:  2013-09-04       Impact factor: 3.561

4.  Health seeking behavior among cancer patients attending Ocean Road Cancer Institute, Tanzania.

Authors:  Methods R Kazaura; Dominista Kombe; Safina Yuma; Hussein Mtiro; Genoveva Mlawa
Journal:  East Afr J Public Health       Date:  2007-04

5.  Setting up a community-based cervical screening service in a low-income country: a pilot study from north-western Tanzania.

Authors:  Nestory Masalu; Patrizia Serra; Dino Amadori; Jackson Kahima; Charles Majinge; Joyce Rwehabura; Oriana Nanni; Sara Bravaccini; Maurizio Puccetti; Rosario Tumino; Lauro Bucchi
Journal:  Int J Public Health       Date:  2017-04-19       Impact factor: 3.380

6.  The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study.

Authors:  Katherine E Gallagher; Tusajigwe Erio; Kathy Baisley; Shelley Lees; Deborah Watson-Jones
Journal:  BMC Health Serv Res       Date:  2018-03-12       Impact factor: 2.655

7.  Cervical Cancer Awareness among Women in Tanzania: An Analysis of Data from the 2011-12 Tanzania HIV and Malaria Indicators Survey.

Authors:  Fabiola V Moshi; Elisa B Vandervort; Stephen M Kibusi
Journal:  Int J Chronic Dis       Date:  2018-05-02

8.  Comprehensive knowledge about cervical cancer is low among women in Northwest Ethiopia.

Authors:  Frehiwot Getahun; Fekadu Mazengia; Mulunesh Abuhay; Zelalem Birhanu
Journal:  BMC Cancer       Date:  2013-01-02       Impact factor: 4.430

9.  Utilization of cervical cancer screening services and its associated factors among primary school teachers in Ilala Municipality, Dar es Salaam, Tanzania.

Authors:  Neema Minja Kileo; Denna Michael; Nyasule Majura Neke; Candida Moshiro
Journal:  BMC Health Serv Res       Date:  2015-12-15       Impact factor: 2.655

10.  Knowledge towards cervical cancer prevention and screening practices among women who attended reproductive and child health clinic at Magu district hospital, Lake Zone Tanzania: a cross-sectional study.

Authors:  Mabula M Mabelele; John Materu; Faraja D Ng'ida; Michael J Mahande
Journal:  BMC Cancer       Date:  2018-05-16       Impact factor: 4.430

View more
  2 in total

1.  Patients' pathways to cancer care in Tanzania: documenting and addressing social inequalities in reaching a cancer diagnosis.

Authors:  Fortunata Songora Makene; Richard Ngilangwa; Cristina Santos; Charlotte Cross; Twalib Ngoma; Phares G M Mujinja; Marc Wuyts; Maureen Mackintosh
Journal:  BMC Health Serv Res       Date:  2022-02-12       Impact factor: 2.655

2.  Acceptability of text messages and knowledge change for cervical cancer screening: a Tanzanian mixed methods study.

Authors:  Kristian Foldager Løkke; Vibeke Rasch; Julius Mwaiselage; Tine Gammeltoft; Ditte Søndergaard Linde
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.